CalciMedica (CALC) reporting person holds 0 shares after amendment

Rhea-AI Filing Summary

CalciMedica, Inc. filing amendment states that the reporting person, Jorey Chernett, no longer beneficially owns any shares of the company's common stock as of the close of business on May 19, 2026.

This Amendment No. 1 is an exit filing reflecting zero shares beneficially owned and reports 0% ownership of the class.

Insights

Corporate Governance Analyst

Exit filing: reporting person reduced beneficial ownership to zero.

The amendment states that Jorey Chernett no longer beneficially owns any common shares of CalciMedica as of May 19, 2026. The filing is administrative and documents a completed change in beneficial ownership.

Timing and method of the prior disposition are not described in the excerpt; subsequent filings or transaction disclosures would be required to show how or when shares were transferred.

Equity Compliance Specialist

Forms show ownership status change, not a securities offer.

The Schedule 13G/A amendment records that the Reporting Person's beneficial ownership is now 0 shares (0%). The cover items and Item 4 supply the ownership status and CUSIP 38942Q202.

This is a routine ownership update; the filing does not state proceeds, counterparties, or transaction mechanics.

Key Figures

CUSIP: 38942Q202 Beneficial ownership: 0 shares Percent of class: 0% +2 more

5 metrics

CUSIP 38942Q202 Common Stock CUSIP listed on cover page

Beneficial ownership 0 shares As of the close of business on May 19, 2026

Percent of class 0% As of the close of business on May 19, 2026

Par value $0.0001 per share Common Stock par value stated on cover

Signature date 05/20/2026 Amendment signed by Reporting Person

Key Terms

Amendment No. 1, Schedule 13G/A, beneficially owned

3 terms

Amendment No. 1 regulatory

"This Amendment No. 1 constitutes an exit filing for the Reporting Person"

Schedule 13G/A regulatory

"Form type indicated as SCHEDULE 13G/A in metadata and cover"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned financial

"the Reporting Person no longer beneficially owned any shares of Common stock"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

CalciMedica, Inc.

(Name of Issuer)

Common Stock, $0.0001 Par Value Per Share

(Title of Class of Securities)

38942Q202

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 38942Q202

1

Names of Reporting Persons

Chernett Jorey

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: This Amendment No. 1 constitutes an exit filing for the Reporting Person (as defined below), as the Reporting Person no longer beneficially owns any shares of the Issuer.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: CalciMedica, Inc.
(b)	Address of issuer's principal executive offices: 505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
Item 2.
(a)	Name of person filing: Jorey Chernett (the "Reporting Person")
(b)	Address or principal business office or, if none, residence: The principal business address of the Reporting Person is 6222 Indianwood Trail, Bloomfield Hills, MI 48301.
(c)	Citizenship: US
(d)	Title of class of securities: Common Stock, $0.0001 Par Value Per Share
(e)	CUSIP No.: 38942Q202
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: As of the close of business on May 19, 2026, the Reporting Person no longer beneficially owned any shares of Common stock, par value $0.0001 per share, of the Issuer ("Shares").
(b)	Percent of class: As of the close of business on May 19, 2026, the Reporting Person no longer beneficially owned any Shares.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Cover Pages Items 5-9.
	(ii) Shared power to vote or to direct the vote: See Cover Pages Items 5-9.
	(iii) Sole power to dispose or to direct the disposition of: See Cover Pages Items 5-9.
	(iv) Shared power to dispose or to direct the disposition of: See Cover Pages Items 5-9.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Chernett Jorey

Signature:	/s/ Jorey Chernett
Name/Title:	Jorey Chernett
Date:	05/20/2026

FAQ

What does CalciMedica (CALC) Schedule 13G/A Amendment No. 1 state?

It states that reporting person Jorey Chernett no longer beneficially owned any common shares as of May 19, 2026. The amendment serves as an exit filing reflecting 0 shares and 0% ownership of the class.

How many CalciMedica shares did the reporting person own after the amendment?

After the amendment the reporting person owned 0 shares of common stock as of the close of business on May 19, 2026, and the filing lists the percent of class as 0%.

Who signed the CalciMedica Schedule 13G/A Amendment No. 1?

The amendment is signed by Jorey Chernett with a signature date of 05/20/2026. The signature attests that the Reporting Person no longer beneficially owns any shares as of May 19, 2026.

Does the amendment disclose how the CalciMedica shares were disposed of?

The amendment does not describe the mechanics, counterparties, or proceeds of any disposition. It only states that the Reporting Person no longer beneficially owned shares as of May 19, 2026.